ADAM17 and cystic fibrosis: Indeed, in both COPD and CF, ADAM17 and the consequent EGFR signaling can be aberrantly activated, thereby leading to airway epithelial cell wound healing, abnormal airway proliferation, maintenance of barrier integrity and progressive lung tissue scarring that are features of both diseases [121,122].